How many insider trades does FilingIQ track for RZLT?

FilingIQ tracks 173 Form 4 insider transactions for RZLT (Rezolute, Inc.), covering filings from Apr 26, 2019 onwards. 4 of those were filed in the last 90 days.

Are RZLT insiders net buyers or net sellers?

Across the full Form 4 history for RZLT, 131 transactions (76%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does RZLT insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is RZLT in?

Rezolute, Inc. (RZLT) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $299.53M.

RZLT insider trading

NasdaqCM Healthcare

Rezolute, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

173

Last 90 days

Buys / sells

76% / 0%

Market cap

$299.53M

About Rezolute, Inc.

Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. Its lead clinical asset is ersodetug, an intravenously administered human monoclonal antibody that is in Phase 3 clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder, as well as for the treatment of hypoglycemia; and clinical trials of ersodetug for tumor hyperinsulinism. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was founded in 2010 and is headquartered in Redwood City, California.

Company website: www.rezolutebio.com

RZLT insider activity at a glance

FilingIQ has scored 173 insider transactions for RZLT since Apr 26, 2019. The most recent filing in our index is dated Mar 30, 2026.

Across the full history, 131 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on RZLT insider trades is 57.3/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live RZLT trades on FilingIQ Raw filings on SEC EDGAR

Latest RZLT Form 4 filings

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

13F funds holding RZLT

Opaleye Management Inc.

$14.84M · 2.0% of AUM

Nantahala Capital Management, LLC

$12.86M · 0.8% of AUM

Frequently asked

How many insider trades does FilingIQ track for RZLT?: FilingIQ tracks 173 Form 4 insider transactions for RZLT (Rezolute, Inc.), covering filings from Apr 26, 2019 onwards. 4 of those were filed in the last 90 days.
Are RZLT insiders net buyers or net sellers?: Across the full Form 4 history for RZLT, 131 transactions (76%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does RZLT insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is RZLT in?: Rezolute, Inc. (RZLT) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $299.53M.

Methodology & sources

Every RZLT insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.